There is still significant unmet need within select cardiovascular/metabolic (CVM) disorders. Unfortunately, the cost of developing drugs and devices in this area has been rising steadily.
Heart disease is the leading cause of death in the world. It accounts for more than 17 million deaths a year and that figure is rising. Pharsh Pharma is primarily focused on developing new strategies for the prevention of heart diseases with particular emphasis on key cardiovascular indications such as high blood pressure, cholesterol, heart failure, lipid disorder through drug and device interventions.